At the news
? NEUTRALIMPACT 5/10 PRESS-RELEASE filed Nov 9, 2026 at 01:00 ET
argenx announces acquisition of Unnatural Products (UNP) for up to $1.15 billion, adding a macrocyclic peptide discovery platform. The deal includes $550M upfront cash and up to $595M in milestone payments, expected to close by year-end.
- Upfront payment of $550 million in cash on hand
- Up to $595 million in development and regulatory milestone payments
- Total potential consideration up to approximately $1.15 billion
- UNP to continue operating from Santa Cruz, California with current team
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access